Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2012, Article ID 860954, 6 pages
http://dx.doi.org/10.1155/2012/860954
Review Article

Sodium Consumption: An Individual's Choice?

1Departments of Medicine, of Community Health Sciences, and of Physiology and Pharmacology, Libin Cardiovascular Institute, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, Canada T2N 4Z6
2Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB, Canada T2N 1N4

Received 29 August 2011; Accepted 14 November 2011

Academic Editor: Simon L. Bacon

Copyright © 2012 Norm R. C. Campbell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, “Global status report on non-communicable diseases 2010,” Geneva, Switzerland, WHO, 2010.
  2. World Health Organization, “Prevention of cardiovascular disease: Guidelines for assessment and management of cardiovascular risk,” Geneva, Switzerland, WHO, 2007.
  3. F. M. Sacks, L. P. Svetkey, W. M. Vollmer et al., “Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet,” The New England Journal of Medicine, vol. 344, no. 1, pp. 3–10, 2001. View at Publisher · View at Google Scholar
  4. F. J. He and G. A. MacGregor, “Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health,” Journal of Human Hypertension, vol. 16, no. 11, pp. 761–770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. F. J. He and G. A. MacGregor, “Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials,” The Lancet, vol. 378, no. 9789, pp. 380–382, 2011. View at Publisher · View at Google Scholar
  6. F. J. He and G. A. MacGregor, “Salt and cardiovascular disease mortality,” The Lancet, vol. 377, no. 9778, p. 1626, 2011. View at Google Scholar
  7. K. Bibbins-Domingo, G. M. Chertow, P. G. Coxson et al., “Projected effect of dietary salt reductions on future cardiovascular disease,” The New England Journal of Medicine, vol. 362, no. 7, pp. 590–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Asaria, D. Chisholm, C. Mathers, M. Ezzati, and R. Beaglehole, “Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use,” The Lancet, vol. 370, no. 9604, pp. 2044–2053, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. World Health Organization, “Creating an enabling environment for population-based salt reduction strategies,” Report of a joint technical meeting held by WHO and the Food Standards Agency, UK, WHO, 2010.
  10. N. R. C. Campbell, B. Legowski, and B. Legetic, “Mobilising the Americas for dietary salt reduction,” The Lancet, vol. 377, no. 9768, pp. 793–795, 2011. View at Publisher · View at Google Scholar
  11. World Health Organization, “Reducing Salt Intake in Populations,” Report of a WHO Forum and Technical Meeting 5–7 October, 2006 Paris, France, 1–65, WHO, 2007.
  12. F. J. He and G. A. MacGregor, “A comprehensive review on salt and health and current experience of worldwide salt reduction programmes,” Journal of Human Hypertension, vol. 23, no. 6, pp. 363–384, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Danaei, E. L. Ding, D. Mozaffarian et al., “The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors,” PLoS Medicine, vol. 6, no. 4, Article ID e1000058, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Webster, E. K. Dunford, C. Hawkes, and B. C. Neal, “Salt reduction initiatives around the world,” Journal of Hypertension, vol. 29, no. 6, pp. 1043–1050, 2011. View at Publisher · View at Google Scholar
  15. World Health Organization, “Reducing Salt Intake in Populations,” Report of a WHO Forum and Technical Meeting 5–7 October 2006, 1–56, WHO, 2007.
  16. J. E. Henny, C. L. Taylor, C. S. Boon et al., Strategies to Reduce Sodium Intake in the United States, National Academies Press, Washington, DC, USA, 2010.
  17. S. Mohan, N. R. C. Campbell, and K. Willis, “Effective population-wide public health interventions to promote sodium reduction,” Canadian Medical Association Journal, vol. 181, no. 9, pp. 605–609, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. J. He and G. A. MacGregor, “How far should salt intake be reduced?” Hypertension, vol. 42, no. 6, pp. 1093–1099, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Palar and R. Sturm, “Potential societal savings from reduced sodium consumption in the U.S. adult population,” American Journal of Health Promotion, vol. 24, no. 1, pp. 49–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. F. J. He and G. A. MacGregor, “Reducing population salt intake worldwide: from evidence to implementation,” Progress in Cardiovascular Diseases, vol. 52, no. 5, pp. 363–382, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. N. van Vliet and J. P. Montani, “The time course of salt-induced hypertension, and why it matters,” International Journal of Obesity, vol. 32, supplement 6, pp. S35–S47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. D. Mickleborough, M. R. Lindley, and S. Ray, “Dietary salt, airway inflammation, and diffusion capacity in exercise-induced asthma,” Medicine and Science in Sports and Exercise, vol. 37, no. 6, pp. 904–914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. F. P. Cappuccio, R. Kalaitzidis, S. Duneclift, and J. B. Eastwood, “Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism,” Journal of Nephrology, vol. 13, no. 3, pp. 169–177, 2000. View at Google Scholar · View at Scopus
  24. F. J. He, N. M. Marrero, and G. A. MacGregor, “Salt intake is related to soft drink consumption in children and adolescents: a link to obesity?” Hypertension, vol. 51, no. 3, pp. 629–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. S. B. Eaton and M. Konner, “Paleolithic nutrition. A consideration of its nature and current implications,” The New England Journal of Medicine, vol. 312, no. 5, pp. 283–289, 1985. View at Google Scholar · View at Scopus
  26. S. B. Eaton and S. B. Eaton III, “Paleolithic vs. modern diets—selected pathophysiological implications,” European Journal of Nutrition, vol. 39, no. 2, pp. 67–70, 2000. View at Google Scholar · View at Scopus
  27. D. M. Lloyd-Jones, Y. Hong, D. Labarthe et al., “Defining and setting national goals for cardiovascular health promotion and disease reduction: the american heart association's strategic impact goal through 2020 and beyond,” Circulation, vol. 121, no. 4, pp. 586–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. Centers for Disease Control and Prevention (CDC), “Application of lower sodium intake recommendations to adults—United States, 1999–2006,” Morbidity and Mortality Weekly Report, vol. 58, no. 11, pp. 281–283, 2009. View at Google Scholar
  29. Panel on Dietary Reference Intakes for Electrolytes and Water and Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Dietary Reference Intakes for Water, Potassium, Sodium, Chloride and Sulfate, National Academies Press, Washington, DC, USA, 2004.
  30. I. J. Brown, I. Tzoulaki, V. Candeias, and P. Elliott, “Salt intakes around the world: implications for public health,” International Journal of Epidemiology, vol. 38, no. 3, pp. 791–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. C. A. M. Anderson, L. J. Appel, N. Okuda et al., “Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP Study,” Journal of the American Dietetic Association, vol. 110, no. 5, pp. 736–745, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Elliott, J. Stamler, R. Nichols et al., “Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations,” British Medical Journal, vol. 312, no. 7041, pp. 1249–1253, 1996. View at Google Scholar · View at Scopus
  33. Sodium Working Group, Sodium Reduction Strategy for Canada. Sodium Reduction, Health Canada, Ottawa, Canada, 2010.
  34. D. Garriguet, “Sodium consumption at all ages,” Health Reports, vol. 18, no. 2, pp. 47–52, 2007. View at Google Scholar · View at Scopus
  35. J. He, L. G. Ogden, S. Vupputuri, L. A. Bazzano, C. Loria, and P. K. Whelton, “Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults,” Journal of the American Medical Association, vol. 282, no. 21, pp. 2027–2034, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. R. D. Mattes and D. Donnelly, “Relative contributions of dietary sodium sources,” Journal of the American College of Nutrition, vol. 10, no. 4, pp. 383–393, 1991. View at Google Scholar · View at Scopus
  37. G. Reboldi, G. Gentile, F. Angeli, and P. Verdecchia, “Blood pressure lowering in the oldest old,” Journal of Hypertension, vol. 28, no. 7, pp. 1373–1376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. R. Joffres, N. R. C. Campbell, B. Manns, and K. Tu, “Estimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in Canada,” Canadian Journal of Cardiology, vol. 23, no. 6, pp. 437–443, 2007. View at Google Scholar · View at Scopus
  39. G. Wang and D. Labarthe, “The cost-effectiveness of interventions designed to reduce sodium intake,” Journal of Hypertension, vol. 29, no. 9, pp. 1693–1699, 2011. View at Publisher · View at Google Scholar
  40. R. Beaglehole, R. Bonita, R. Horton et al., “Priority actions for the non-communicable disease crisis,” The Lancet, vol. 377, no. 9775, pp. 1438–1447, 2011. View at Publisher · View at Google Scholar
  41. World Health Organization, “Strategies to monitor and evaluate population sodium consumptions and sources of sodium in the diet,” Canada, WHO, 2010.
  42. M. E. Gee, A. Bienek, N. R. C. Campbell et al., “Prevalence of, and barriers to, preventative lifestyle behaviors in hypertension (from a national survey of Canadians with hypertension),” American Journal of Cardiology. In press. View at Publisher · View at Google Scholar
  43. World Health Organization, “Reducing salt intake in populations,” Report of a WHO forum and technical meeting. Paris, France, WHO, 2006.
  44. L. J. Cobiac, T. Vos, and J. L. Veerman, “Cost-effectiveness of interventions to reduce dietary salt intake,” Heart, vol. 96, no. 23, pp. 1920–1925, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Elliott, “Taste rules! food marketing, food law, and childhood obesity in Canada,” Journal of Canadian Food Cultures, vol. 1, no. 1, pp. 1–9, 2008. View at Google Scholar
  46. P. W. F. Fischer, M. Vigneault, R. Huang, K. Arvaniti, and P. Roach, “Sodium food sources in the Canadian diet,” Applied Physiology, Nutrition and Metabolism, vol. 34, no. 5, pp. 884–892, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. Decima Research, “Canadians' and health care professionals' views on sodium,” Final Report, Public Health Agency of Canada, Toronto, Canada, 2009. View at Google Scholar
  48. L. Hooper, C. Bartlett, G. D. Smith, and S. Ebrahim, “Systematic review of long term effects of advice to reduce dietary salt in adults,” British Medical Journal, vol. 325, no. 7365, pp. 628–632, 2002. View at Google Scholar · View at Scopus
  49. N. Sasaki, “The salt factor in apoplexy and hypertension: epidemiological studies in Japan,” in Prophylactic Approach to Hypertensive Diseases, Y. Yamori, Ed., pp. 467–474, Raven Press, New York, NY, USA, 1979. View at Google Scholar
  50. H. Karppanen and E. Mervaala, “Sodium Intake and Hypertension,” Progress in Cardiovascular Diseases, vol. 49, no. 2, pp. 59–75, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Pietinen, L. M. Valsta, T. Hirvonen, and H. Sinkko, “Labelling the salt content in foods: a useful tool in reducing sodium intake in Finland,” Public Health Nutrition, vol. 11, no. 4, pp. 335–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Laatikainen, P. Pietinen, L. Valsta, J. Sundvall, H. Reinivuo, and J. Tuomilehto, “Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population,” European Journal of Clinical Nutrition, vol. 60, no. 8, pp. 965–970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. L. J. Appel, M. W. Brands, S. R. Daniels, N. Karanja, P. J. Elmer, and F. M. Sacks, “Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association,” Hypertension, vol. 47, no. 2, pp. 296–308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. F. J. He and G. A. MacGregor, “Can a low-sodium, high-potassium salt substitute reduce blood pressure in rural Chinese people? Commentary,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 4, pp. 186–187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Li, J. Liu, D. Song et al., “Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial,” Journal of Hypertension, vol. 25, no. 10, pp. 2011–2018, 2007. View at Publisher · View at Google Scholar
  56. Scientific Advisory Committee on Nutrition, Salt and Health, Scientific Advisory Committee on Nutrition, The Stationery Office, Norwich, UK, 2003.
  57. World Health Organization, “WHO Framework Convention on Tobacco Control,” World Health Organization, Geneva, Switzerland, 2003.
  58. K. S. Okuyemi, N. L. Nollen, and J. S. Ahluwalia, “Interventions to facilitate smoking cessation,” American Family Physician, vol. 74, no. 2, pp. 262–271, 2006. View at Google Scholar · View at Scopus
  59. A. Bandura, “Self-efficacy mechanism in psychobiologic functioning,” in Self-Efficacy: Thought Control of Action, R. Schwarzer, Ed., Hemisphere, Washington, DC, USA, 1992. View at Google Scholar
  60. S. A. Shumaker, J. K. Ockene, and K. A. Riekert, The Handbook of Health Behavior Change, Springer, New York, NY, USA, 3rd edition, 2008.
  61. W. R. Miller and P. L. Wilbourne, “Mesa grande: a methodological analysis of clinical trials of treatments for alcohol use disorders,” Addiction, vol. 97, no. 3, pp. 265–277, 2002. View at Publisher · View at Google Scholar · View at Scopus
  62. M. J. Armstrong, T. A. Mottershead, P. E. Ronksley, R. J. Sigal, T. S. Campbell, and B. R. Hemmelgarn, “Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials,” Obesity Reviews, vol. 12, no. 9, pp. 709–723, 2011. View at Publisher · View at Google Scholar
  63. G. Ogedegbe, W. Chapli, A. Schoenthaler et al., “A practive-based trial of motivational interviewing and adherence in hypertensive African Amercians,” American Journal of Hypertension, vol. 21, pp. 1137–1143, 2008. View at Google Scholar
  64. W. R. Miller and S. Rollnich, Motivational Interviewing: Preparing People for Change, Guilford Press, New York, NY, USA, 2002.
  65. J. Mu, Z. Liu, F. Liu, X. Xu, Y. Liang, and D. Zhu, “Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents,” American Journal of Hypertension, vol. 22, no. 9, pp. 943–947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. World Health Organization, “Salt as a Vehicle for Fortification,” Report of a WHO Expert Consultation. WHO; 1: 1–27, 2008.